Advocacy intelligence hub — real-time data for patient organizations
Health and Research-Insights — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Myozyme
(Recombinant human acid alpha-glucosidase; alglucosidase alfa)Orphan drugstandardGenzyme Corporation
Paul Orchard, M.D., MD
Masonic Cancer Center, University of Minnesota
📍 MINNEAPOLIS, MN
Kenneth Setchell, PhD
Children's Hospital Medical Center, Cincinnati
James Heubi, MD
Children's Hospital Medical Center, Cincinnati
Nancy Braverman, PhD, MD, M.D
Montreal Children's Hospital, MUHC
📍 BALTIMORE, MD
Ravi Vij, M.D., MD
Washington Universtiy in St. Louis
📍 SAINT LOUIS, MO
Emine Tekin
Giresun University